Dacomitinib and gedatolisib in combination with fractionated radiation in head and neck cancer.

Wilson, George D; Wilson, Thomas G; Hanna, Alaa; Dabjan, Mohamad; Buelow, Katie; Torma, John; Marples, Brian; Galoforo, Sandra

Wilson, George D; Wilson, Thomas G; Hanna, Alaa; Dabjan, Mohamad; Buelow, Katie; Torma, John; Marples, Brian; Galoforo, Sandra.

Afiliación

Wilson GD; Department of Radiation Oncology, William Beaumont Hospital, Royal Oak, MI, United States.
Wilson TG; Department of Radiation Oncology, William Beaumont Hospital, Royal Oak, MI, United States.
Hanna A; Department of Radiation Oncology, William Beaumont Hospital, Royal Oak, MI, United States.
Dabjan M; Department of Radiation Oncology, William Beaumont Hospital, Royal Oak, MI, United States.
Buelow K; Department of Radiation Oncology, William Beaumont Hospital, Royal Oak, MI, United States.
Torma J; Department of Radiation Oncology, William Beaumont Hospital, Royal Oak, MI, United States.
Marples B; Department of Radiation Oncology, University of Rochester, Rochester, NY, United States.
Galoforo S; Department of Radiation Oncology, William Beaumont Hospital, Royal Oak, MI, United States.

Clin Transl Radiat Oncol ; 26: 15-23, 2021 Jan.

Article en En | MEDLINE | ID: mdl-33251343

Palabras clave

Growth delay; Head and neck cancer; Radiation; Targeted agents; Xenografts

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Clin Transl Radiat Oncol Año: 2021 Tipo del documento: Article País de afiliación: Estados Unidos Pais de publicación: Irlanda

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google